HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Use of the new hypotensive agent Minipress (prazosin hydrochloride].

Abstract
Efficacy of minipress in patients with hypertension stage II and its haemodynamic effects were studied after a single administration and during a course of treatment. It is shown that its main mechanism is in vasodilatation caused by relaxation of the muscular component of arterioles. The authors suggest that minipress can produce redistribution of the blood through peripheral venoconstriction. Decrease of the index of the external work of the heart points indirectly to decreased oxygen utilization by the myocardium which may reflect changes in haemodynamics under the influence of minipress or through direct action of the drug on the heart. Hypotensive effect of minipress is recorded already by the 5th day of its administration (p less than 0.001), however, its further effect is unstable. Increase of the circadian dose becomes necessary and also its combined use with thiazide diuretics. Positive chronotropic effect of Minipress has been recorded, with maximum towards the end of the 2nd week of treatment and seen as increased rate of cardiac contractions by 13.2% (p less than 0.01). To decrease this effect authors advise to use minipress in combination with beta-adrenoblockers.
AuthorsV G Kukes, S B Zisel'man, G B Shustikova, A S Rumiantsev, E V Shagako
JournalKardiologiia (Kardiologiia) Vol. 22 Issue 3 Pg. 46-50 (Mar 1982) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitlePrimenenie nocogo gipotenzivnogo sredstva minipress )prazosin hydrochloride).
PMID7077901 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Quinazolines
  • Prazosin
Topics
  • Adult
  • Antihypertensive Agents (therapeutic use)
  • Chronic Disease
  • Drug Evaluation
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Prazosin (administration & dosage, therapeutic use)
  • Quinazolines (therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: